An opportu_老虎社区_美港股上老虎

KenKen88
2021-10-30

An opportunity to increase the revenue

Moderna to supply 56.5 mln more doses of its COVID-19 shot to vaccine alliance GAVI

Oct 29 (Reuters) - Moderna Inc on Friday announced a pact with the GAVI vaccine alliance to supply a

Moderna to supply 56.5 mln more doses of its COVID-19 shot to vaccine alliance GAVI

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":857287199,"tweetId":"857287199","gmtCreate":1635529952326,"gmtModify":1635529952326,"author":{"id":4088068388931720,"authorId":4088068388931720,"authorIdStr":"4088068388931720","name":"KenKen88","avatar":"https://static.tigerbbs.com/e94d6d2e19c3be869d6e5a1be1b30107","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>An opportunity to increase the revenue&nbsp;</p></body></html>","htmlText":"<html><head></head><body><p>An opportunity to increase the revenue&nbsp;</p></body></html>","text":"An opportunity to increase the revenue","highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/857287199","repostId":2179241848,"repostType":4,"repost":{"id":"2179241848","pubTimestamp":1635520629,"share":"https://www.laohu8.com/m/news/2179241848?lang=&edition=full","pubTime":"2021-10-29 23:17","market":"us","language":"en","title":"Moderna to supply 56.5 mln more doses of its COVID-19 shot to vaccine alliance GAVI","url":"https://stock-news.laohu8.com/highlight/detail?id=2179241848","media":"Reuters","summary":"Oct 29 (Reuters) - Moderna Inc on Friday announced a pact with the GAVI vaccine alliance to supply a","content":"<p>Oct 29 (Reuters) - Moderna Inc on Friday announced a pact with the GAVI vaccine alliance to supply a further 56.5 million doses of its COVID-19 vaccine in the second quarter of next year to low- and middle-income countries.</p>\n<p>The vaccine maker said the doses will be in addition to an earlier commitment to supply 60 million doses in the second quarter of 2022 to GAVI, which co-leads the COVAX facility for equitable distribution of COVID-19 shots around the world.</p>\n<p>The COVAX facility, backed by the World Health Organization and GAVI, has delivered some 400 million COVID-19 vaccine doses to more than 140 low- and middle-income countries, but several countries run the risk of failing to meet WHO's target of 40% vaccination coverage by year-end.</p>\n<p>Moderna said the doses will be offered at a low price and GAVI continues to retain the option to procure 233 million additional doses in 2022, for a potential total of 500 million doses between this year and next.</p>\n<p>\"We have recently offered to COVAX to access more vaccines for Q2 and Q3 2022,\" Moderna Chief Executive Officer Stéphane Bancel said.</p>\n<p>The company earlier this month announced an investment of up to $500 million to build a facility in Africa with the goal of producing up to 500 million doses of mRNA vaccines each year, including its COVID-19 shot.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna to supply 56.5 mln more doses of its COVID-19 shot to vaccine alliance GAVI</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna to supply 56.5 mln more doses of its COVID-19 shot to vaccine alliance GAVI\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-29 23:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-moderna-supply-56-5-150350680.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Oct 29 (Reuters) - Moderna Inc on Friday announced a pact with the GAVI vaccine alliance to supply a further 56.5 million doses of its COVID-19 vaccine in the second quarter of next year to low- and ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-moderna-supply-56-5-150350680.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/1-moderna-supply-56-5-150350680.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2179241848","content_text":"Oct 29 (Reuters) - Moderna Inc on Friday announced a pact with the GAVI vaccine alliance to supply a further 56.5 million doses of its COVID-19 vaccine in the second quarter of next year to low- and middle-income countries.\nThe vaccine maker said the doses will be in addition to an earlier commitment to supply 60 million doses in the second quarter of 2022 to GAVI, which co-leads the COVAX facility for equitable distribution of COVID-19 shots around the world.\nThe COVAX facility, backed by the World Health Organization and GAVI, has delivered some 400 million COVID-19 vaccine doses to more than 140 low- and middle-income countries, but several countries run the risk of failing to meet WHO's target of 40% vaccination coverage by year-end.\nModerna said the doses will be offered at a low price and GAVI continues to retain the option to procure 233 million additional doses in 2022, for a potential total of 500 million doses between this year and next.\n\"We have recently offered to COVAX to access more vaccines for Q2 and Q3 2022,\" Moderna Chief Executive Officer Stéphane Bancel said.\nThe company earlier this month announced an investment of up to $500 million to build a facility in Africa with the goal of producing up to 500 million doses of mRNA vaccines each year, including its COVID-19 shot.","news_type":1},"isVote":1,"tweetType":1,"viewCount":709,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":33,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

Moderna to supply 56.5 mln more doses of its COVID-19 shot to vaccine alliance GAVI

评论（1）

热议股票